PTC Therapeutics, Inc.
PTCT
$48.19
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 38.22% | -7.54% | -8.30% | 41.22% | -17.16% |
| Total Depreciation and Amortization | 4.29% | -7.58% | -87.33% | -31.36% | 30.05% |
| Total Amortization of Deferred Charges | 2.33% | 1.69% | -0.34% | -1.00% | -47.82% |
| Total Other Non-Cash Items | -159.55% | -58.71% | -23.20% | -27.97% | 18.20% |
| Change in Net Operating Assets | 272.04% | 187.96% | -117.06% | 179.30% | -1,200.59% |
| Cash from Operations | 61.03% | -7.75% | -200.98% | 170.56% | -590.74% |
| Capital Expenditure | -621.65% | -107.08% | 176.92% | -72.26% | 12.44% |
| Sale of Property, Plant, and Equipment | -100.00% | -99.94% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 743.76% | 58.38% | 3.80% | -18.56% | -282.34% |
| Cash from Investing | 727.33% | 35.27% | 42.64% | -21.73% | -219.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 99.50% | -- |
| Issuance of Common Stock | 4,519.72% | -87.78% | 131.03% | -16.05% | -29.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -107.53% | -- | -- | 1,080,178.82% |
| Cash from Financing | 250.17% | -107.15% | 45,544.81% | -99.91% | 18,361.32% |
| Foreign Exchange rate Adjustments | -201.30% | 264.68% | -155.52% | -165.59% | 232.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 298.46% | -223.90% | 327.59% | -110.65% | 1,095.39% |